Know More About Breast Cancer | Max Healthcare

Get Second Opinion

Doc Connect

Hospital : 
Max Super Speciality Hospital, Saket
  • Robotic Urological Surgery: 15 years journey 
    Dr. Rahul Yadav, Dr. Anant Kumar
  • Robotic surgery is the latest in advanced onco surgical procedures 
    Dr. Harit Chaturvedi
  • Percutaneous balloon aortic valvuloplasty & balloon dilatation of aortic coarctation in a 10 year old child 
    Dr. Neeraj Awasthy, Dr. Sushil Shukla
  • Role of CT/MR imaging and echocardiography in evaluation of valsalva sinus aneurysm 
    Dr. Reena Anand, Dr. Raj Kumar, Dr. Divya Malhotra, Dr. Bharat Aggarwal
  • Risk factors for patients undergoing treatment for Breast Cancer
    Ms. Kanika Arora, Ms. Ritika Samaddar
  • Radiology Case of The Month 
    Dr. Nafisa Shakir Batta, Dr. Dhruv Jain
October, 2015 :15
Emergency Call Button

DELHI / NCR : 011-4055 4055

MOHALI : 0172-665 2666

DEHRADUN : 0135-667 3666

BATHINDA : 0164-660 1666

New Stent Prices

Sr. No. Type Name of Manufacturer Price to Patient (Including local taxes per NPPA order) for Delhi, UP & Uttarakhand Price to Patient (Including local taxes per NPPA order) for Haryana Price to Patient (Including local taxes per NPPA order) for Punjab
1 Xience Prime Drug Eluting Stent Abbott Healthcare Pvt.Ltd 24999 24999 24999.00
2 Xience V Everolimus Eluting Coronary Stent Abbott Healthcare Pvt.Ltd 24999 24999 24999.00
3 Endeavor Sprint Stent India Medtronic Pvt. Ltd 31080 31080 31635.00
4 Biomime Drug Eluting Stent Meril Lifesciences Ltd 31080 31080 31635.00
5 Metafor Drug Eluting Stent Meril Lifesciences Ltd 31080 31080 31635.00
6 Supraflex Sirolimus Eluting Stent Sahajanand Medical Technologies Pvt Ltd 31080 31080 31635.00
7 Yukon Choice Flex Stent Translumina Therapeutics LLP 31080 31154 31635.00
8 Cobal+C Mini Stent Relisys Medical Devices Ltd 7623 7641 7759

Know More About Breast Cancer

Home >> Blogs >> Cancer Care Oncology Surgical Oncology >> Know More About Breast Cancer

Clinical Directorate

For more info please call 011-4732 6969, 9999 777 754, or mail at

Breast Cancer

Know More About Breast Cancer

Dr. Vivek Gupta
Senior Consultant – Surgical Oncology
Cancer Care / Oncology, Surgical Oncology

Breast Cancer is becoming more and more common in younger age group and 50 % cases are now seen in 35 to 60 years of age group especially in India.

Breast cancer has evolved into one of the most easily detectable cancer of the mankind. It is so far the most researched cancer and that is the reason that a significant success has been achieved towards its treatment.  Breast Cancer may in times to come, become a lifestyle disease just like hypertension and diabetes.  Even Stage IV patients are now having good survival benefits.

In India, there are approximately 1.5 lakh new cases of breast cancer that are diagnosed every year.

Risk Factors

The primary risk factors for breast cancer are female sex and older age. Other potential risk factors include: genetics, lack of childbearing or lack of breastfeeding, higher levels of certain hormones, certain dietary patterns, and obesity.

Common Symptoms of Breast Cancer

  • Lump in the breast.
  • Change in Nipple shape or retraction.
  • Thickening of the skin
  • Lump in the armpit.
  • Abnormal nipple discharge.

These are some of the common symptoms to determine breast cancer which need to be further investigated. But the best treated breast cancer is the one which is detected on screening, i.e before the symptoms could develop. This is because it is a very early stage and if treated properly, usually results in curing the disease.

What are the screening methods in breast cancer?

Screening is to detect a disease early. In breast cancer this can be done by:

  • clinical and self breast exams
  • mammography
  • genetic screening
  • ultrasound
  • magnetic resonance imaging.

A clinical or self breast exam involves feeling the breast for lumps or other abnormalities. Clinical breast exams are performed by health care providers, while self breast exams are performed by the person themselves. Evidence does not support the effectiveness of either type of breast exam, as by the time a lump is large enough to be found it is likely to have been growing for several years and thus soon be large enough to be found without an exam. Mammographic screening for breast cancer uses X-rays to examine the breast for any uncharacteristic masses or lumps. During a screening, the breast is compressed and a technician takes photos from multiple angles. USG of the breast is a better modality for screening in younger (pre-menopausal) women.


For any cancer diagnosis, a BIOPSY is must. It is a myth that doing biopsy spreads the disease. Any needle or incision biopsy is the only definite diagnosis for cancer. Similarly in breast cancer needle biopsy in the form of FNAC or Tru-cut biopsy is required to arrive at the diagnosis.

Tru-cut biopsy is the preferred modality of biopsy for breast cancer because it also gives us information about the receptor status which is very important to plan the treatment of breast cancer patient.

Biopsy does not result in spread of disease.


The sequence of treatment modality is of outmost importance.

The management of breast cancer depends on various factors, including the stage of the cancer and the age of the patient and receptor status. Nowadays we have multiple treatment options in breast cancer with surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy, etc.

We can preserve the breast nowadays with breast conservation surgeries and even more and more plastic reconstructions are employed nowadays to give a better cosmesis to the breast cancer patients.

A multidisciplinary approach is preferable. Hormone receptor-positive cancers are often treated with hormone-blocking therapy over courses of several years. Monoclonal antibodies, or other immune-modulating treatments, may be administered in certain cases of metastatic and other advanced stages of breast cancer.